SEP 11, 2026 · PHASE 2 TRIAL
COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
ClinicalTrials.gov
This is an active Phase 2 interventional trial with no results reported; the registry record describes planned enrollment and endpoints only, not outcomes.
Reported
Planned enrollment56
PhasePhase 2
Primary outcome measureNumber of patients free of progression at 6…